Health Care & Life Sciences – Page 211 – Indianapolis Business Journal

Dow AgroSciences ratcheting up biotech efforts

October 7, 2009

Dow AgroSciences’ introduction of a promising new product is helping transform the Indianapolis company as it transitions
from a focus on traditional agricultural chemicals to genetically altered seeds. The subsidiary of Michigan-based Dow Chemical
Co. partnered with St. Louis-based Monsanto Co. to develop what could become its biggest blockbuster, a genetically modified
corn variety it calls SmartStax.

Indiana life sciences leaders discover dozens of tiny outsourcing companies

October 7, 2009

BioCrossroads, an Indianapolis-based not-for-profit, is cataloging Indiana businesses offering contract services to pharmaceutical
and biotechnology companies, and discovering many small firms operating in relative obscurity.

Lilly settles Zyprexa suit with S. Carolina

October 7, 2009

Eli Lilly and Co. has agreed to settle the State of South Carolina’s lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.

Dow AgroSciences and the Holy Grail

October 7, 2009

Dow AgroSciences could boost its market share in genetically altered corn almost overnight by inventing a perennial corn.
But investors might not have the patience.

Proposed Fishers medical park faces uncertain demand

October 6, 2009

Fishers development officials hope to create a huge cluster of medical and research facilities near Interstate 69’s Exit
10, near St. Vincent Medical Center Northeast, but local real estate experts disagree about the amount of potential demand
for such a development.

Health reform could swamp doctors

October 1, 2009

Health reform that would cover millions of uninsured Americans would theoretically send a flood of new
patients to physicians. Yet in Indiana and nationwide, there’s already a shortage of doctors.

IUPUI researchers land $22M in stimulus grants

October 1, 2009

Researchers at IUPUI have been awarded more than $22.3 million in grants by the National Institutes of Health, according to
U.S. Rep. Andre Carson. The money is part of a $5 billion program that was part of the federal stimulus bill approved earlier
this year, and will fund medical research across the country.

Proposed Medicaid change splits state nursing homes

October 1, 2009

The Indiana Division of Aging wants to change Medicaid rates to nursing homes to reward quality care and penalize the lack
of it, leaving the industry divided over whether to support the groundbreaking rule or to seek revisions and a slower phase-in.

Dow Agro to become Purdue research tenant

September 30, 2009

Officials of Purdue University and Dow AgroSciences unveiled a collaboration Wednesday in which the Indianapolis-based company
will become one of the largest tenants at the Purdue Research Park in West Lafayette.

Indiana hospitals settle Medicare lawsuit

September 30, 2009

Six hospital systems, including three in Indiana, have agreed to pay the federal government $8.3 million to settle a whistleblower
lawsuit alleging the hospitals deliberately overcharged Medicare for routine back surgeries.

Connecticut gets $25 million from Zyprexa lawsuit

September 29, 2009

Connecticut officials say Eli Lilly and Co. has agreed to a $25 million settlement with the state over claims the drug maker
marketed its anti-psychotic drug, Zyprexa, for unapproved uses and harmed patients.

St. Francis resumes work on $265M project

September 25, 2009

With its financial performance exceeding expectations, St. Francis Hospital & Health Centers will resume construction on a $265 million, 221-bed patient tower at its Indianapolis campus, the hospital system announced Thursday.

Hospitals, doctors finally integrating patient care

September 24, 2009

The stitching together of doctors and hospitals—two groups that historically have kept each other at arm’s length—is
a trend picking up speed locally and nationally and could accelerate even further if Congress passes health care reform.

Clarian CEO pines anew for public insurance option

September 24, 2009

Most business groups cheered when Sen. Max Baucus, D-Mont., introduced a health reform bill with no so-called public option,
a controversial government-run insurance plan for working adults. But there’s a big group that would like
to see it back on the table—hospitals.

Region below average on Obama’s health care cost measure

September 24, 2009

The tool the administration is using to measure waste shows that expenses in Indianapolis might be low enough
not to get whacked. But the region isn’t performing so well that it’s likely to get much praise, either.

Lilly’s win in Evista patent case crucial, analyst says

September 24, 2009

A decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.’s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.

Judge upholds Lilly’s Evista patent

September 24, 2009

A federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.

Lilly Endowment funds OrthoWorx effort with $7 million

September 23, 2009

A new group expected to develop the orthopedic implants industry in Warsaw will be able to proceed now that Indianapolis-based
Lilly Endowment Inc. is putting $7 million behind it, according to an announcement this morning.

Health insurer WellPoint may cut more jobs

September 22, 2009

Health insurer WellPoint said today that it may trim some more jobs as part of a push to become more efficient next year.

Lilly agrees to settle more state Zyprexa suits

September 22, 2009

Eli Lilly and Co. has agreed to confidential terms to settle lawsuits brought by seven states alleging the company illegally
marketed bestselling antipsychotic drug Zyprexa, Bloomberg News reported today.

Articles